ArticleAnnals of translational medicine2019

Nivolumab without brain radiotherapy is insufficient for the treatment of most patients with brain metastases from clear cell renal cell carcinoma.

Amit K Chowdhry et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.